Differential inhibitory effect of regular inhaled corticosteroid on airway responsiveness to adenosine 5' monophosphate, methacholine, and bradykinin in symptomatic children with recurrent wheeze

Pediatric Pulmonology

Volumn 23, Issue 6, 1997, Pages 404-411

  Doull, Iolo J M ^a,b   Sandall, Deborah ^a   Smith, Sandra ^a   Schreiber, Jacqueline ^a   Freezer, Nicholas J ^a   Holgate, Stephen T ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

AMP; Bradykinin; Children; Inhaled corticosteroids; Methachollne

Indexed keywords

ADENOSINE KINASE; BECLOMETASONE DIPROPIONATE; BRADYKININ; METHACHOLINE;

ARTICLE; BRONCHUS REACTIVITY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; WHEEZING;

ADENOSINE MONOPHOSPHATE; ADMINISTRATION, INHALATION; AIRWAY RESISTANCE; ANTI-INFLAMMATORY AGENTS; AREA UNDER CURVE; BECLOMETHASONE; BRADYKININ; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTOR AGENTS; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; METHACHOLINE CHLORIDE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; RESPIRATORY FUNCTION TESTS; RESPIRATORY SOUNDS;

EID: 0030818711     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199706)23:6<404::AID-PPUL2>3.0.CO;2-I     Document Type: Article

References (31)

1. Juniper EF, Frith PA, Hargreave FE. Airway responsiveness to histamine and methacholine: Relationship to minimum treatment to control symptoms of asthma. Thorax. 1981; 36:575-579.
2. Kirby JG, Hargreave FE, Gleich GJ, O'Byrne PM. Bronchoalveolar cell profiles of asthmatic and no asthmatic subjects. Am Rev Respir Dis. 1987; 136:379-383.
3. Beasley CRW, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi of mild asthma and after bronchial provocation. Am Rev Respir Dis. 1989; 139:806-817.
4. Sears MR, Jones DT, Holdaway MD, Hewitt CJ, Flannery EM, Herbison GP, Silva PA. Prevalence of bronchial reactivity to inhaled methacholine in New Zealand children. Thorax. 1986; 41: 283-289.
5. Salome CM, Peat JK, Woolcock AJ. Bronchial hyperresponsiveness in two populations of Australian school children. I: Relation of respiratory symptoms and diagnosed asthma. Clin Allergy. 1987; 17:271-282.
6. Pattemore PK, Asher MI, Harrison AC, Mitchell EA, Rea HH, Stewart AW. The interrelationship among bronchial hyperresponsiveness, the diagnosis of asthma, and asthma symptoms. Am Rev Respir Dis. 1990; 142:549-554.
7. Ryan G, Latimer KM, Juniper EF, Roberts RF, Hargreave FE. Effect of beclomethasone dipropionate on bronchial responsiveness to histamine in controlled non-steroid dependent asthma. J Allergy Clin Immunol. 1985; 75:25-30.
8. Djukanovic R, Wilson JW, Britten KM, Wilson SJ, Walls AW, Roche WR, Howarth PH, Holgate ST. Effect of inhaled corticosteroid on airway inflammation and symptoms of asthma. Am Rev Respir Dis. 1992; 145:669-674.
9. Bel EH, Timmers MC, Hermans J, Dijkman JH, Sterk PJ. The long term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacholine in non atopic asthmatic subjects. Am Rev Respir Dis. 1990; 141:21-28.
10. Bel EH, TImmers MC, Zwinderman AH, Dijkman JH, Sterk PJ. The effect of inhaled corticosteroids on the maximal degree of airway narrowing to methacholine in asthmatic subjects. Am Rev Respir Dis. 1991; 143:109-113.
11. Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O'Bryne PM, Hargreave FE. Effect of long term treatment with an inhaled corticosteroid (Budesonide) on airway hyperresponsiveness and clinical asthma in non-steroid dependent asthmatics. Am Rev Respir Dis. 1990; 142:832-836.
12. Vathenen AS, Knox AJ, Wisniewski A, Tattersfield AE. Effect of inhaled Budesonide on bronchial reactivity to histamine, exercise and eucapnic dry air hyperventilation in patients with asthma. Thorax. 1991; 46:811-816.
13. Dutoit JI, Salome CM, Woolcock AJ. Inhaled corticosteroids reduce the severity of bronchial responsiveness in asthma but oral theophylline does not. Am Rev Respir Dis. 1987; 136:1174-1178.
14. Bhasat RG, Grunstein MM. Effect of corticosteroids on bronchial responsiveness to methacholine in asthmatic children. Am Rev Respir Dis. 1985; 131:902-906.
15. Kerrebijn KF, Van Essen-Zandvliet EE, Neijens HJ. Effect of long term treatment with inhaled corticosteroids and beta agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol. 1987; 79:653-659.
16. Van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ, Kerrebijn KF. Effects of 22 months of treatment with inhaled corticosteroids and/or beta 2 agonists on lung function, airway responsiveness and symptoms in children with asthma. Am Rev Respir Dis. 1992; 146:547-554.
17. Kraemer R, Sennhauser F, Reinhardt M. Effects of regular inhalation of beclomethasone dipropionate and sodium cromoglycate on bronchial hyperreactivity in asthmatic children. Acta Paediatr Scand. 1987; 76:119-123.
18. Polosa R, Church MK, Holgate ST. The mode of action of airway responses to adenosine in asthma. Immunol Allergy Clin North Am. 1990; 10.2:363-372.
19. Chan W, Cushley MJ, Holgate ST. The effect of inhaled adenosine 5′ monophosphate (AMP) on airway calibre in normal and asthmatic subjects. Clin Sci. 1986; 70:65-66.
20. Cushley MJ, Tattersfield AE, Holgate ST. Inhaled adenosine, guanosine on air way resistance in normal and asthmatic subjects. Br J Clin Pharmacol. 1983; 15:161-165.
21. O'Connor BJ, Ridge SM, Barnes PJ, Fuller RW. Greater effect of inhaled budesonide on adenosine 5′ monophosphate induced than on sodium metabisulfide-induced bronchoconstriction in asthma. Am Rev Respir Dis. 1992; 146:560-564.
22. Avital A, Springer C, Bar-Yishay E, Godfrey S. Adenosine, methacholine, and exercise challenges in children with asthma or paediatric chronic obstructive pulmonary disease. Thorax. 1995; 50:511-516.
23. van Velzen E, van den Bos J-W, Benckhuijsen JAW, van Essel T, de Bruijn R, Aalbers R. Effect of allergen avoidance at high altitude on direct and indirect bronchial hyperresponsiveness and markers of inflammation in children with allergic asthma. Thorax. 1996; 51:582-584.
24. Polosa R, Holgate ST. Comparative airway responses to inhaled bradykinin, kallidid and [desArg]-bradykinin in normal and asthmatic airways. Am Rev Respir Dis. 1990; 142:1367-1371.
25. 2 and thromboxane prostanoid receptors. Am J Respir Crit Care Med. 1994; 150:1012-1018.
26. Fuller RW, Dixon CMS, Cuss FMC, Barnes PJ. Bradykinin induced bronchoconstriction in adults. Mode of action. Am Rev Respir Dis. 1987; 135:176-180.
27. Varonier MS, Panzani R. The effects of inhalations of bradykinin on healthy children and atopic (asthmatic) children. Int Arch Allergy. 1968; 34:293-296.
28. Doull IJM, Freezer NJ, Holgate ST. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med. 1995; 151:1715-1719.
29. Yan K, Salome C, Woolcock AJ. Rapid method for measurement of bronchial responsiveness. Thorax. 1983; 38:760.
30. Schleimer RP, MacGlashan DW, Peters SP, Pinckard RN, Adkinson NF, Lichtenstein LM. Characterisation of inflammatory mediator release from purified human lung mast cells. Am Rev Respir Dis. 1986; 133:614-617.
31. Cockroft DW, Murdock KY. Comparative effects of inhaled salbutamol, sodium cromoglycate and BDP on allergen induced early asthmatic responses, late asthmatic responses and increased bronchial hyperresponsiveness to histamine. J Allergy Clin Immunol. 1987; 79:734-740.